Stein J - Search Results

1

The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.

Daniel C, Radeke HH, Sartory NA, Zahn N, Zuegel U, Steinmeyer A, Stein J. Daniel C, et al. Among authors: stein j. J Pharmacol Exp Ther. 2006 Nov;319(2):622-31. doi: 10.1124/jpet.106.107599. Epub 2006 Aug 16. J Pharmacol Exp Ther. 2006. PMID: 16914561

2

FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.

Daniel C, Sartory NA, Zahn N, Schmidt R, Geisslinger G, Radeke HH, Stein JM. Daniel C, et al. Mol Immunol. 2007 Jul;44(13):3305-16. doi: 10.1016/j.molimm.2007.02.026. Epub 2007 May 1. Mol Immunol. 2007. PMID: 17475330

3

Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.

Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Daniel C, et al. J Pharmacol Exp Ther. 2008 Jan;324(1):23-33. doi: 10.1124/jpet.107.127209. Epub 2007 Oct 2. J Pharmacol Exp Ther. 2008. PMID: 17911375

4

ZK 156718, a low calcemic, antiproliferative, and prodifferentiating vitamin D analog.

Gaschott T, Steinmeyer A, Steinhilber D, Stein J. Gaschott T, et al. Among authors: stein j. Biochem Biophys Res Commun. 2002 Jan 11;290(1):504-9. doi: 10.1006/bbrc.2001.6213. Biochem Biophys Res Commun. 2002. PMID: 11779200

5

Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis.

Reuter KC, Grunwitz CR, Kaminski BM, Steinhilber D, Radeke HH, Stein J. Reuter KC, et al. Among authors: stein j. J Pharmacol Exp Ther. 2012 Apr;341(1):68-80. doi: 10.1124/jpet.111.183947. Epub 2012 Jan 10. J Pharmacol Exp Ther. 2012. PMID: 22235147

6

22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities.

Daniel C, Schlauch T, Zügel U, Steinmeyer A, Radeke HH, Steinhilber D, Stein J. Daniel C, et al. Among authors: stein j. Eur J Clin Invest. 2005 May;35(5):343-9. doi: 10.1111/j.1365-2362.2005.01492.x. Eur J Clin Invest. 2005. PMID: 15860047

7

The TGFbeta/Smad 3-signaling pathway is involved in butyrate-mediated vitamin D receptor (VDR)-expression.

Daniel C, Schroder O, Zahn N, Gaschott T, Steinhilber D, Stein JM. Daniel C, et al. J Cell Biochem. 2007 Dec 15;102(6):1420-31. doi: 10.1002/jcb.21361. J Cell Biochem. 2007. PMID: 17471513

8

p38 MAPK signaling pathway is involved in butyrate-induced vitamin D receptor expression.

Daniel C, Schröder O, Zahn N, Gaschott T, Stein J. Daniel C, et al. Among authors: stein j. Biochem Biophys Res Commun. 2004 Nov 26;324(4):1220-6. doi: 10.1016/j.bbrc.2004.09.191. Biochem Biophys Res Commun. 2004. PMID: 15504345

9

Butyrate-induced differentiation of Caco-2 cells is mediated by vitamin D receptor.

Gaschott T, Werz O, Steinmeyer A, Steinhilber D, Stein J. Gaschott T, et al. Among authors: stein j. Biochem Biophys Res Commun. 2001 Nov 2;288(3):690-6. doi: 10.1006/bbrc.2001.5832. Biochem Biophys Res Commun. 2001. PMID: 11676498

10

Letter: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis-a unique therapeutic target in inflammatory bowel disease.

Radeke HH, Stein J. Radeke HH, et al. Among authors: stein j. Aliment Pharmacol Ther. 2022 May;55(10):1359. doi: 10.1111/apt.16888. Aliment Pharmacol Ther. 2022. PMID: 35472180 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,932 results

Search Page

Filters